
HeartFlow Inc (HTFL) Stock Forecast & Price Target
HeartFlow Inc (HTFL) Analyst Ratings
Bulls say
HeartFlow is a promising medical technology company with innovative software and AI solutions for diagnosing and managing coronary artery disease. The company is well-positioned for future growth with a strong management team, strategic partnerships, and a favorable environment for adoption. Financially, the company has shown impressive revenue growth and margin expansion, and its premium valuation is justified by its potential for continued success.
Bears say
HeartFlow is heavily reliant on three software products for its revenue, making it vulnerable to any potential failures or disruptions in the market. Additionally, the company's focus on high-risk asymptomatic populations may limit its potential customer base and lead to slower adoption of its technology. This, combined with a relatively small total addressable market, presents a potential risk for the company's future growth and profitability.
This aggregate rating is based on analysts' research of HeartFlow Inc and is not a guaranteed prediction by Public.com or investment advice.
HeartFlow Inc (HTFL) Analyst Forecast & Price Prediction
Start investing in HeartFlow Inc (HTFL)
Order type
Buy in
Order amount
Est. shares
0 shares